This study aimed (1) to evaluate the impact of preprocedural two-dimensional speckle-tracking echocardiography (2D-STE) on long-term outcome after successful percutaneous mitral balloon valvotomy (PMBV) in patients with mitral stenosis (MS) and (2) to determine whether 2D-STE detects underlying diastolic dysfunction as defined by invasive haemodynamic study.
Introduction
Mitral stenosis (MS) continues to be an endemic valvular heart disease worldwide mainly due to the high prevalence of rheumatic fever in developing countries. 1 Treatment for symptomatic moderate to severe MS is based on the mechanical relief of the obstruction either by percutaneous mitral balloon valvotomy (PMBV) or mitral valve surgery. 2 PMBV is the first-line approach for symptomatic patients with severe (MS) and favourable valve morphology. 3 The pre-procedure assessment primarily relies on a semiquantitative scoring system 4 for assessing valve features and commissural calcifications. 5 Various models have been proposed to predict immediate and long-term outcomes. 6 -10 Previous studies have reported the presence of subclinical left ventricular (LV) systolic dysfunction in MS patients. 11, 12 However, the relationship between baseline indexes of myocardial function and long-term outcome after PMBV has not been described. We have recently shown that the presence of LV diastolic dysfunction defined as an elevated LV end-diastolic pressure (LVEDP) at the time of haemodynamic catheterization was associated with reduced improvement in symptoms despite successful PMBV. 13 In our previous report, we were unable to show a correlation between traditional echocardiographic measures of LV systolic and diastolic functions and patient outcomes. Indeed, this confirms the current view that preprocedural transthoracic echocardiographic evaluation of LV diastolic function remains particularly challenging due to altered mitral inflow caused by the stenotic mitral valve. We hypothesized that myocardial deformation imaging may overcome these limitations and could provide outcome information. Therefore, the purpose of this study was to (i) evaluate the impact of preprocedural abnormal systolic LV deformation on long-term outcome after successful PMBV in patients with MS and (ii) determine whether 2D-STE myocardial strain parameters allow identification of MS patients with underlying diastolic LV dysfunction as defined by invasive haemodynamic study.
Methods

Study population and data collection
Consecutive patients with preserved LV ejection fraction (LVEF ≥50%) who underwent PMBV procedure at Mayo Clinic, Rochester from September 2003 through September 2011 for symptomatic rheumatic MS were included in the study if they had at least one digitally stored comprehensive transthoracic echocardiogram within 8 weeks prior to their PMBV procedure. 
Speckle-tracking echocardiography
Images were imported into a workstation equipped with vendorindependent software for analysis of myocardial strain (Syngo VVI, Siemens Medical Solution, Inc.). We have previously shown that this software produces accurate results. 16 The software automatically divides the entire LV into six equal segments per chamber view ( Figure 1) . Peak global longitudinal strain (GLS), peak systolic strain rate (SRs), and peak early diastolic strain rate (SRe) were obtained from the average of 18 segments computed from four-chamber, three-chamber, and twochamber views. All 2D-STE values were averaged for three cycles. Mean acquisition frame rate was 48 frames/s.
Haemodynamic catheterization and PMBV
Right and left catheterization with transseptal atrial puncture was performed in all patients for haemodynamic assessment of LVEDP, left atrial pressure (LAP), right ventricular and pulmonary artery pressures (PAP) measured before and after valvuloplasty as previously described. 13 Diastolic dysfunction was defined as preprocedural elevation in LVEDP (.15 mmHg). 13, 17 See expanded methods in the Supplementary data online.
Study endpoints
The primary endpoint was defined as all-cause mortality. The secondary endpoint was a composite of death or mitral valve reintervention, defined as either repeat PMBV or mitral valve surgery. Follow-up was concluded on 31 January 2014; the timing from PMBV procedure to first event was taken into account for survival analysis. Outcome data were obtained from Mayo Clinic electronic records, and death was also ascertained through Social Security Death Index. Long-term event-free survival for all-cause mortality and mitral valve reintervention were estimated by the Kaplan -Meier method. Further confirmation of risk was performed using Cox proportional-hazards regression analysis. For the primary endpoint, the most significant variable at univariate analysis was entered in the multivariate Cox model. For the composite endpoint, we performed stepwise forward selection including variables with P , 0.15 or on the basis of their potential clinical relevance. The incremental value of risk factors was assessed by the overall difference between models using the log-likelihood x 2 model. In order S. Barros-Gomes et al.
Statistical analysis
to identify the best GLS cutoff values we constructed ROC curves for the primary and secondary endpoints. A multivariable logistic regression analysis was used to determine whether SRe, SRs, and GLS were associated with increased LVEDP after adjustment for age, LV mass index, effective arterial elastance (afterload), and LV end-diastolic volume index (preload). 18 The cohort was then divided into 2 groups according to the peak GLS indicated by ROC curve: Group 1 (GLS . 216%) and Group 2 (GLS ≤ 216%). Table 1 provides baseline demographic characteristics. All patients were symptomatic, 47 (73%) had New York Heart Association III symptoms, and 17 (27%) had class II symptoms. Among those with prior procedures, 3 (5%) had previous PMBV, and 3 (5%) had surgical commissurotomy. There were no statistically significant differences between groups in terms of medical therapy at the baseline and time delay between initial echocardiography and PMBV.
Echocardiographic results are detailed in Table 2 . Subjects with impaired GLS (Group 1) were more likely to have lower LVEF, lower stroke volume index, and higher resting heart rate compared with Group 2. In addition, Group 1 patients had somewhat lower MVA, and slightly higher mean gradients, pressure half time, and systolic PAP than patients with higher strain values (Group 2), but none of these differences reached statistical significance.
Preprocedural LAP was greater in Group 1 (mean + SD, 23.0 + 5.0 vs. 20.0 + 6.7 mmHg; P ¼ 0.03). Patients in Group 1 tended to have higher pre-PMBV mitral mean gradients, mean PAP, LVEDP, and lower MVA by Gorlin formula compared with Group 2, although these differences were not statistically significant ( Table 3) . Moderate mitral regurgitation after valvuloplasty was seen in six patients, equally distributed between groups. 
Long-term outcome
Predictors of outcome
Results of the Kaplan-Meier analysis for death and composite endpoint (death and reintervention) are presented in Figure 2 .
In a Cox proportional-hazard regression analysis ( The additional benefit of GLS in predicting events is illustrated in Figure 3 . The model that contains GLS added incremental value over age in all-cause mortality ( Figure 3A) , and over mitral mean gradient and LAP in the composite endpoint prior and after PMBV, respectively ( Figure 3B) . In order to explore the predictive role of variables that are primarily influenced by the immediate procedure, we included final haemodynamic measurements in the composite endpoint model, such as post-PMBV mitral mean gradient, MVA, and mean PAP ( Figure 3C ).
Post-procedural speckle-tracking strain analysis
Fifteen out of 64 subjects had repeated echocardiographic examinations within 3 months to the procedure [median (IQR), 40 days (21-76 days)]. Majority of the patients had a statistically significant improvement in GLS after procedure (pre-and post-procedural GLS mean difference, 21.67%, P ¼ 0.01). This increase was of lower magnitude in patients who subsequently presented with events compared with those without (mean difference, 20.985 vs. 22.97%, respectively; P ¼ 0.03) (see the Supplementary data online).
Speckle-tracking strain and diastolic dysfunction
Of the 64 subjects, 45 (70%) had normal filling pressures (LVEDP ≤15 mmHg) and 19 (30%) had elevated filling pressures (LVEDP .15 mmHg). In our series, 2D-STE parameters were unable to detect the presence of LV diastolic dysfunction defined as elevated LVEDP (. Group 1 was more likely to have higher afterload and lower preload, as shown by higher effective arterial elastance and reduced LV end-diastolic volume index compared with those in Group 2 ( Table 2) .
Discussion
To the best of our knowledge, this is the first study to demonstrate the prognostic importance of LV longitudinal strain measurements on long-term outcome after successful PMBV in patients with MS. Our results demonstrate that (i) GLS by 2D-STE predicts long-term Strain and outcome in mitral stenosis all-cause mortality and the composite of all-cause mortality and mitral reintervention after successful PMBV; (ii) GLS has incremental prognostic value over traditional clinical, echocardiographic, and invasive haemodynamic parameters; and (iii) longitudinal 2D-STE indexes (SRe, SRs, and GLS) were unable to detect diastolic dysfunction in MS patients, even after adjustments for changes in cardiac load and structure.
This cohort focuses in patients with good immediate results of PMBV. Since the advent of PMBV, the rationale for identifying candidates with more favourable characteristics by assessing clinical, haemodynamic, and mitral valve anatomic parameters has been crucial to predict long-term outcome in patients with MS. 7 -10,14 It is well established that late functional results are primary influenced by immediate results. 7, 9, 10 To eliminate their influence, all patients with suboptimal immediate outcome were excluded from the final analysis. Previous studies in MS patients have reported better event-free survival in younger patients. 7, 14 Our cohort consists of older patients, with long-standing disease, and non-pliable mitral valves, which may be associated with less favourable profile. As such, the 10-year event-free survival for the composite endpoint (death or reintervention) was 39% in patients with normal strain, similar to previous studies in similar age cohorts. 19 Importantly, GLS was an independent predictor of all-cause mortality after adjustment for important predictors at multivariate model. This relationship underscores the importance of preprocedural GLS in detecting subclinical systolic LV dysfunction, which may directly influence outcome despite successful PMBV. In addition, GLS incrementally improved the risk stratification over traditional markers. These data have important implications when counselling patients prior to PMBV.
Myocardial and haemodynamic factors that may play a role in LV dysfunction in MS patients include restrictive filling from either inflammatory process or thickening of the mitral apparatus with tethering effect, 20 altered loading conditions, 21 reduced LV compliance, 22 and right -left ventricular interdependence. 23 Traditionally, LVEF is usually well preserved in MS patients, and symptoms are generally attributed to increased LAP and pulmonary capillary pressure as a result of LV inflow obstruction. However, previous studies using TDI 11, 12 or 2D-STE 24 -26 have demonstrated subclinical LV dysfunction in a number of MS patients with normal LVEF. Interestingly, Bilen et al. 24 have correlated the GLS values with MS severity and found that impaired myocardial deformation was associated with higher mitral gradients and lower MVAs. We noted a similar trend in our study, but differences did not reach statistical significance. Nonetheless, patients with more impaired GLS (Group 1) had higher invasive LAP. They had lower stroke volume, LVEF, LV end-diastolic index, and higher heart rates compared with Group 2. These changes may be the result of either reduced preload, subclinical myocardial dysfunction, or both.
Further supporting the contribution of preload alteration in generating abnormal longitudinal strain in MS are the results of Sengupta et al. 26 Indeed, in their study, GLS improved immediately after PMBV, in parallel with improvement in haemodynamics. The authors found that LV end-diastolic volume was a stronger independent determinant of GLS values at baseline and after PMBV. We observed similar results in our small group of patients who underwent postprocedural echocardiography, with improved GLS in all patients.
However, the increase in GLS seemed of smaller magnitude in patients who subsequently presented with events, suggesting the presence of underlying myocardial dysfunction. These findings must, however, be interpreted cautiously as follow-up echocardiography data were available only in 25% of patients. In our cohort, strain data were adjusted for changes in cardiac load. Besides that, 30% of MS patients had preprocedural increase in LVEDP, indicating some degree of pre-existing myocardial diastolic dysfunction hence intrinsic myocardial disease. Furthermore, our study included older patients, with hypertension, vascular occlusive peripheral and coronary disease, which are known risk factors for heart failure with preserved LVEF. 27 We found no correlation between strain indexes Strain and outcome in mitral stenosis and LVEDP. This underscores the need for other noninvasive approaches to diagnose diastolic dysfunction in MS patients. 28 Strain is affected by changes in loading conditions, although less than other traditional parameters such as LVEF or mitral inflow velocities. In our series, subjects with impaired GLS (Group 1) had higher afterload compared with those in Group 2, which in part may explain the decrease in GLS. 29 On the other hand, this group had higher heart rate which itself may increase the contractility. 30 However, further studies in atropine-induced tachycardia had shown no inotropic effect of tachycardia on GLS, despite marginal effect in other deformation indices. 31 Witkowski et al. 32 found that a baseline GLS of .219.9% was the major independent predictor of long-term LV dysfunction after mitral valve repair for mitral regurgitation. This is higher than the typical 218% normal cutoff value for GLS and reflects the increased LV preload and reduced afterload in the presence of mitral regurgitation. Conversely, current study found lower GLS cutoffs (216% for composite endpoint and 213% for death), which matches the MS physiology characterized by reduced LV preload. It is well known that reduced LVEF is an adverse prognostic factor in patients with valvular disease. Such fact, the assessment of LV myocardial function plays an important role in predicting outcome after cardiac surgery. 2 However, this parameter relies on geometric assumptions, adequate endocardial border definition, and is highly influenced by several physiologic variables. We believe that the assessment of more sensitive parameters, like GLS, can detect early changes in intrinsic myocardial function and may be able to predict outcome, optimizing the selection of candidates for intervention. Moreover, incorporation of GLS into the current score system would improve risk stratification and therapeutic choices, with powerful impact on clinical decision-making. Current valvular heart disease 3 and imaging guidelines 33 do not discuss the role of strain imaging in valvular heart disease, nor do they comment on diseasespecific strain cutoffs. This gap in knowledge hampers the adoption of strain imaging for routine evaluation in valvular disease.
Limitations
This is a retrospective, single-centre study, with a relatively small sample size and relatively few events; therefore, further confirmation is needed in larger prospective cohorts. In addition, this cohort is representative of MS patients in the USA. Our results may not be similar in a younger population with less severe morphological deformity of the valve and/or myocardium. Strain data in this study were only analysed from VVI software, and results cannot be extended to other systems since differences in strain values across vendors may be seen. However, this was previously shown to have reproducible results with vendor-specific software packages. 16 In this study, 2D-STE was performed on stored digital images at relatively low frame rates. As such, peak SRs are likely underestimated due to low sampling rate and could explain in part the lack of difference between groups in terms of diastolic strain assessment. We have focused on GLS that is a robust parameter; this approach was shown to produce accurate results when directly compared with on-board strain software packages. 16 Although echocardiographic and catheterization data were obtained in close temporal relation, measurements were not performed simultaneously.
Conclusion
GLS is a strong predictor of long-term outcome after successful PMBV and provides incremental prognostic value over traditional parameters. Echocardiographic diagnosis of diastolic dysfunction in MS patients remains elusive.
